Stewardship in sepsis

• Autores: José Luis del Pozo
• Localización: Revista Española de Quimioterapia, ISSN-e 0214-3429, Vol. 32, Nº Extra 2 (September 2019, Suppl.2), 2019, págs. 42-46
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Sepsis is the major cause of mortality from any infectious disease worldwide. The goals of antimicrobial stewardship are to achieve optimum clinical outcomes and to ensure cost effectiveness and minimum unintended consequences, including toxic effects, selection of pathogenic organisms, and resistance. The combination of inadequate diagnostic criteria for sepsis with the extraordinary time pressure to provide broad-spectrum antimicrobial therapy is troubling from a stewardship perspective. Use of empirical therapy according to guidelines, de-escalation of therapy, switch from intravenous to oral therapy, therapeutic drug monitoring, use of a list of restricted antibiotics, and bedside consultation can lead to significant benefits for clinical outcomes, adverse events, and costs.